BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36252552)

  • 1. UHPLC-ESI-MS/MS assay for quantification of endocannabinoids in cerebrospinal fluid using surrogate calibrant and surrogate matrix approaches.
    Aydin E; Cebo M; Mielnik J; Richter H; Schüle R; Sievers-Engler A; Młynarz P; Lämmerhofer M
    J Pharm Biomed Anal; 2023 Jan; 222():115090. PubMed ID: 36252552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and application of an LC-MS/MS method for quantitation of three fatty acid ethanolamides as biomarkers for fatty acid hydrolase inhibition in human plasma.
    Jian W; Edom R; Weng N; Zannikos P; Zhang Z; Wang H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1687-99. PubMed ID: 20462810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous ethanolamide analysis in human plasma using HPLC tandem MS with electrospray ionization.
    Palandra J; Prusakiewicz J; Ozer JS; Zhang Y; Heath TG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(22):2052-60. PubMed ID: 19535304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative profiling of endocannabinoids and related compounds in rat brain using liquid chromatography-tandem electrospray ionization mass spectrometry.
    Richardson D; Ortori CA; Chapman V; Kendall DA; Barrett DA
    Anal Biochem; 2007 Jan; 360(2):216-26. PubMed ID: 17141174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A column switching ultrahigh-performance liquid chromatography-tandem mass spectrometry method to determine anandamide and 2-arachidonoylglycerol in plasma samples.
    Marchioni C; de Souza ID; Grecco CF; Crippa JA; Tumas V; Queiroz MEC
    Anal Bioanal Chem; 2017 May; 409(14):3587-3596. PubMed ID: 28337517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of endocannabinoids in murine plasma and brain substructures by surrogate-based LC-MS/MS: Application in tumor-bearing mice.
    Gong Y; Li X; Kang L; Xie Y; Rong Z; Wang H; Qi H; Chen H
    J Pharm Biomed Anal; 2015; 111():57-63. PubMed ID: 25863017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of endocannabinoids in plasma samples by biocompatible solid-phase microextraction devices coupled to mass spectrometry.
    Acquaro Junior VR; Goméz-Ríos GA; Tascon M; Costa Queiroz ME; Pawliszyn J
    Anal Chim Acta; 2019 Dec; 1091():135-145. PubMed ID: 31679567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of endocannabinoids in postmortem brain of schizophrenic subjects.
    Muguruza C; Lehtonen M; Aaltonen N; Morentin B; Meana JJ; Callado LF
    Schizophr Res; 2013 Aug; 148(1-3):145-50. PubMed ID: 23800614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of anandamide, oleoylethanolamide and palmitoylethanolamide in rodent brain tissue using high performance liquid chromatography-electrospray mass spectroscopy.
    Liput DJ; Tsakalozou E; Hammell DC; Paudel KS; Nixon K; Stinchcomb AL
    J Pharm Anal; 2014 Aug; 4(4):234-241. PubMed ID: 25506470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation and validation of a UHPLC-MS/MS method for quantification of the endocannabinoids AEA and 2-AG in cerebral interstitial fluid and plasma.
    Weiermair T; Svehlikova E; Magnes C; Boulgaropoulos B; Altendorfer-Kroath T; Hummer J; Eberl A
    J Pharm Biomed Anal; 2024 Jan; 238():115844. PubMed ID: 37979522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast accurate quantification of salivary cortisol and cortisone in a large-scale clinical stress study by micro-UHPLC-ESI-MS/MS using a surrogate calibrant approach.
    Aydin E; Drotleff B; Noack H; Derntl B; Lämmerhofer M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Oct; 1182():122939. PubMed ID: 34547590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Troubleshooting in LC-MS/MS method for determining endocannabinoid and endocannabinoid-like molecules in rat brain structures applied to assessing the brain endocannabinoid/endovanilloid system significance.
    Bystrowska B; Smaga I; Tyszka-Czochara M; Filip M
    Toxicol Mech Methods; 2014 May; 24(4):315-22. PubMed ID: 24576199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surrogate analyte-based quantification of main endocannabinoids in whole blood using liquid chromatography-tandem mass spectrometry.
    Dong X; Li L; Ye Y; Zhang D; Zheng L; Jiang Y; Shen M
    Biomed Chromatogr; 2019 Mar; 33(3):e4439. PubMed ID: 30444951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Sensitive Ultrahigh-Performance Liquid Chromatography/Tandem Mass Spectrometry Method for the Simultaneous Analysis of Phytocannabinoids and Endocannabinoids in Plasma and Brain.
    Ahmed F; Torrens A; Mahler SV; Ferlenghi F; Huestis MA; Piomelli D
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):371-385. PubMed ID: 36367975
    [No Abstract]   [Full Text] [Related]  

  • 15. LC-MS/MS-ESI method for simultaneous quantitation of three endocannabinoids and its application to rat pharmacokinetic studies.
    Sharma K; Singh RR; Kandaswamy M; Mithra C; Giri S; Rajagopal S; Mullangi R
    Bioanalysis; 2011 Jan; 3(2):181-96. PubMed ID: 21250847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating and hepatic endocannabinoids and endocannabinoid-related molecules in patients with cirrhosis.
    Caraceni P; Viola A; Piscitelli F; Giannone F; Berzigotti A; Cescon M; Domenicali M; Petrosino S; Giampalma E; Riili A; Grazi G; Golfieri R; Zoli M; Bernardi M; Di Marzo V
    Liver Int; 2010 Jul; 30(6):816-25. PubMed ID: 19840245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-analytical sample handling standardization for reliable measurement of metabolites and lipids in LC-MS-based clinical research.
    Sens A; Rischke S; Hahnefeld L; Dorochow E; Schäfer SMG; Thomas D; Köhm M; Geisslinger G; Behrens F; Gurke R
    J Mass Spectrom Adv Clin Lab; 2023 Apr; 28():35-46. PubMed ID: 36872954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validated UPLC-MS/MS method for the analysis of vitamin B
    Rossmann J; Christ S; Richter S; Friedrich Garbade S; Friedrich Hoffmann G; Opladen T; Günther Okun J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Dec; 1212():123503. PubMed ID: 36279779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of endocannabinoids and endocannabinoid-like substances in human K3EDTA plasma - LC-MS/MS method validation and pre-analytical characteristics.
    Gurke R; Thomas D; Schreiber Y; Schäfer SMG; Fleck SC; Geisslinger G; Ferreirós N
    Talanta; 2019 Nov; 204():386-394. PubMed ID: 31357310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography-tandem mass spectrometry.
    Balvers MG; Verhoeckx KC; Witkamp RF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(14-15):1583-90. PubMed ID: 19395322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.